Immunologic Factors in Reflux Esophagitis and Barrett's Esophagus
Immunologic Factors Correlating With Cyclooxygenase and Nitric Oxide Synthase in Reflux Esophagitis and Barrett's Esophagus
Sponsor: National Taiwan University Hospital
This observational or N/A phase trial investigates Hiatal Hernia and Reflux Esophagitis and is currently ongoing. National Taiwan University Hospital leads this study, which shows 7 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2018 — Sep 2020 [monthly]
Unknown Status
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Feb 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Taiwan University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .